ASAM research updates

The American Society of Addiction Medicine collated recent addiction-pharma research: discontinuing buprenorphine and extended-release formulations, barriers to starting buprenorphine in adolescents, Pew tracking state-level efforts to expand methadone access, an opioid overdose vaccine, and initiating buprenorphine in patients using fentanyl.